Jun-Min Zhou

1.0k total citations · 1 hit paper
13 papers, 781 citations indexed

About

Jun-Min Zhou is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Jun-Min Zhou has authored 13 papers receiving a total of 781 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Molecular Biology and 3 papers in Cancer Research. Recurrent topics in Jun-Min Zhou's work include Bioactive Compounds and Antitumor Agents (2 papers), Viral-associated cancers and disorders (2 papers) and Glycosylation and Glycoproteins Research (1 paper). Jun-Min Zhou is often cited by papers focused on Bioactive Compounds and Antitumor Agents (2 papers), Viral-associated cancers and disorders (2 papers) and Glycosylation and Glycoproteins Research (1 paper). Jun-Min Zhou collaborates with scholars based in China, United States and Hong Kong. Jun-Min Zhou's co-authors include Xiao‐Feng Zhu, Richard D. Kim, Taymeyah Al‐Toubah, Amit Mahipal, Baek‐hui Kim, Daneng Li, Dae Won Kim, Vincent Chung, Michael J. Schell and Olatunji B. Alese and has published in prestigious journals such as Journal of Medicinal Chemistry, Molecular Pharmacology and Cancer Letters.

In The Last Decade

Jun-Min Zhou

13 papers receiving 769 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Phase 2 Multi-institutional Study of Nivolumab for Patients With Advanced Refractory Biliary Tract Cancer

2020 306 citations Richard D. Kim, Vincent Chung et al. JAMA Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jun-Min Zhou China	11	355	303	301	116	108	13	781
Eung‐Seok Lee South Korea	8	246 0.7×	164 0.5×	166 0.6×	48 0.4×	81 0.8×	15	572
Youqun Xiang China	17	250 0.7×	347 1.1×	69 0.2×	51 0.4×	73 0.7×	30	734
Chang In Choi South Korea	16	151 0.4×	361 1.2×	165 0.5×	50 0.4×	267 2.5×	43	804
N Saijo Japan	12	277 0.8×	302 1.0×	70 0.2×	53 0.5×	121 1.1×	25	602
Sonam Tulsyan India	15	218 0.6×	283 0.9×	85 0.3×	47 0.4×	73 0.7×	24	600
Setsuo Takeda Japan	14	575 1.6×	347 1.1×	145 0.5×	77 0.7×	367 3.4×	41	991
Liang Yu China	15	192 0.5×	181 0.6×	91 0.3×	46 0.4×	219 2.0×	54	608
Sarinya Kongpetch Thailand	17	219 0.6×	404 1.3×	360 1.2×	17 0.1×	88 0.8×	40	760
Quan Jiang China	15	169 0.5×	213 0.7×	43 0.1×	73 0.6×	115 1.1×	30	534
Shuangjia Wang China	13	242 0.7×	333 1.1×	106 0.4×	27 0.2×	43 0.4×	19	615

Countries citing papers authored by Jun-Min Zhou

Since Specialization

Citations

This map shows the geographic impact of Jun-Min Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun-Min Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun-Min Zhou more than expected).

Fields of papers citing papers by Jun-Min Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun-Min Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun-Min Zhou. The network helps show where Jun-Min Zhou may publish in the future.

Co-authorship network of co-authors of Jun-Min Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Jun-Min Zhou. A scholar is included among the top collaborators of Jun-Min Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun-Min Zhou. Jun-Min Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Reyna, Chantal, Kandace P. McGuire, Weihong Sun, et al.. (2020). Evaluation of 2014 margin guidelines on re-excision and recurrence rates after breast conserving surgery: A multi-institution retrospective study. The Breast. 51. 29–33. 9 indexed citations

Kim, Richard D., Vincent Chung, Olatunji B. Alese, et al.. (2020). A Phase 2 Multi-institutional Study of Nivolumab for Patients With Advanced Refractory Biliary Tract Cancer. JAMA Oncology. 6(6). 888–888. 306 indexed citations breakdown →

Siegel, Erin M., Yuhua Gu, Yoganand Balagurunathan, et al.. (2019). Semiautomated Measure of Abdominal Adiposity Using Computed Tomography Scan Analysis. Journal of Surgical Research. 237. 12–21. 1 indexed citations

Cohen, Allison S., Farah Khalil, Eric A. Welsh, et al.. (2017). Cell-surface marker discovery for lung cancer. Oncotarget. 8(69). 113373–113402. 29 indexed citations

Li, Zhiming, et al.. (2008). Synergistic cytotoxicity of Bcl-xL inhibitor, gossypol and chemotherapeutic agents in non-Hodgkin’s lymphoma cells. Cancer Biology & Therapy. 7(1). 51–60. 22 indexed citations

Zhou, Jun-Min, Yi Wang, He Huang, et al.. (2007). Silencing of LMP1 Induces Cell Cycle Arrest and Enhances Chemosensitivity Through Inhibition of AKT Signaling Pathway in EBV-Positive Nasopharyngeal Carcinoma Cells. Cell Cycle. 6(11). 1379–1385. 59 indexed citations

Zhou, Jun-Min, et al.. (2006). Synthesis and biological evaluation of 4-aryl-5-cyano-2H-1,2,3-triazoles as inhibitor of HER2 tyrosine kinase. Bioorganic & Medicinal Chemistry. 15(3). 1533–1538. 50 indexed citations

Zhu, Xiao‐Feng, et al.. (2005). Blockade of Vascular Endothelial Growth Factor Receptor Signal Pathway and Antitumor Activity of ON-III (2′,4′-Dihydroxy-6′-methoxy-3′,5′-dimethylchalcone), a Component from Chinese Herbal Medicine. Molecular Pharmacology. 67(5). 1444–1450. 59 indexed citations

Zhu, Xiao‐Feng, et al.. (2005). siRNA targeting LMP1-induced apoptosis in EBV-positive lymphoma cells is associated with inhibition of telomerase activity and expression. Cancer Letters. 232(2). 189–198. 39 indexed citations

10.

Zhou, Jun-Min, et al.. (2005). The tumor suppressor p33^ING1benhances taxol-induced apoptosis by p53-dependent pathway in human osteosarcoma U2OS cells. Cancer Biology & Therapy. 4(1). 46–54. 16 indexed citations

11.

Lu, Yu‐Jing, Jun-Min Zhou, Xiao‐Feng Zhu, et al.. (2005). Synthesis and Evaluation of Quindoline Derivatives as G-Quadruplex Inducing and Stabilizing Ligands and Potential Inhibitors of Telomerase. Journal of Medicinal Chemistry. 48(23). 7315–7321. 158 indexed citations

12.

Zhou, Jun-Min, et al.. (2004). Aloe Polysaccharides Mediated Radioprotective Effect through the Inhibition of Apoptosis. Journal of Radiation Research. 45(3). 447–454. 17 indexed citations

13.

Zhou, Jun-Min, et al.. (2003). Manumycin inhibits cell proliferation and the Ras signal transduction pathway in human hepatocellular carcinoma cells. International Journal of Molecular Medicine. 11(6). 767–71. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact